Transthyretin Amyloidosis (ATTR)
Explore our collection of clinical education resources to understand more about the diagnosis, epidemiology, disease burden, and management of transthyretin (ATTR) amyloidosis.
If you cannot find what you are looking for or you have other inquiries, connect with us to contact a Medical Science Liaison or our Medical Information team.
Copy Link
Hereditary ATTR Amyloidosis: A Closer Look at the V122I Variant
V122I is the most common variant of hATTR amyloidosis in the United States and is most prevalent in patients of African American descent. Compared to other variants, patients with the V122I variant experience significant disease burden and poorer outcomes.
Symptoms and Disease Burden of ATTR
This slide deck provides an overview of the symptoms and disease burden of ATTR.
Screening, Recognition, and Barriers to Diagnosis of ATTR
This deck highlights the screening, recognition, and barriers of diagnosis in ATTR.
Hereditary ATTR Amyloidosis: A Closer Look at the V122I Variant
V122I is the most common variant of hATTR amyloidosis in the United States and is most prevalent in patients of African American descent. Compared to other variants, patients with the V122I variant experience significant disease burden and poorer outcomes.
Therapeutic Area Congress Resources
Publications
Publication Date
May 2020
Journal
Amyloid
Authors
Ola Akinboboye, Keyur Shah, Alberta L. Warner, et al.
Publication Date
August 2021
Journal
Circulation: Genomic and Precision Medicine
Authors
Barry Trachtenberg, Sachin Shah, Robert Nussbaum et al
ATTR Diagnostic and Staging Tools
This deck highlights diagnostic and staging tools for assessing patients with ATTR.
Hereditary ATTR Amyloidosis: A Closer Look at the V122I Variant
V122I is the most common variant of hATTR amyloidosis in the United States and is most prevalent in patients of African American descent. Compared to other variants, patients with the V122I variant experience significant disease burden and poorer outcomes.
ATTR Screening and Carrier Management
This deck highlights tools for ATTR screening and recommendations for the management of hATTR carriers.
Diagnosis of ATTR
This deck highlights the red flag symptoms of ATTR and the tools to help achieve an accurate diagnosis.
ATTR Amyloidosis Disease State Handout
This handout provides an overview of ATTR amyloidosis manifestations and the diagnostic tools that can be used to assess their presentation.
Carpal Tunnel Release Surgery Handout
This handout provides an overview of two diagnostic algorithms for ATTR amyloidosis in patients with carpal tunnel syndrome.
Therapeutic Area Congress Resources
Musculoskeletal Manifestations Associated with ATTR Amyloidosis
This slide deck provides disease education on ATTR amyloidosis, focusing on the musculoskeletal manifestations associated with the disease and their importance for early diagnosis and patient care.
Hereditary ATTR Amyloidosis: A Closer Look at the V122I Variant
V122I is the most common variant of hATTR amyloidosis in the United States and is most prevalent in patients of African American descent. Compared to other variants, patients with the V122I variant experience significant disease burden and poorer outcomes.
Symptoms and Disease Burden of ATTR
This slide deck provides an overview of the symptoms and disease burden of ATTR.
Therapeutic Area Congress Resources
Hereditary ATTR Amyloidosis: A Closer Look at the V122I Variant
V122I is the most common variant of hATTR amyloidosis in the United States and is most prevalent in patients of African American descent. Compared to other variants, patients with the V122I variant experience significant disease burden and poorer outcomes.
ATTR Management Guidelines
This deck highlights published guidelines on diagnosis, treatment and disease management of ATTR.
ATTR Screening and Carrier Management
This deck highlights tools for ATTR screening and recommendations for the management of hATTR carriers.
ATTRv-PN Expert Opinion Slide Deck
Recommendations from a panel of experts for the diagnosis and treatment of hereditary transthyretin amyloidosis with polyneuropathy in the United States.
